Heather A. Berger Insider Profile

4 Followers
Heather A. Berger, Director at Entasis Therapeutics Holdings, holds 1.30K shares in Design Therapeutics (Ticker: DSGN), holds 0.00 shares in Entasis Therapeutics Holdings (Ticker: ETTX). Most recently, Heather A. Berger Bought ― shares of Design Therapeutics on Mar 25, 2024 for an estimated value of 4.86K.
tipranks
Heather A. Berger

Heather A. Berger
Entasis Therapeutics Holdings (ETTX)
Director

Not Ranked
Heather A. Berger has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9K
100.00%
A breakdown of Heather A. Berger's holdings

Insider Roles

Design Therapeutics
(DSGN)
Director
Roles that Heather A. Berger holds in companies

Most Profitable Insider Trade

Stock:
Design Therapeutics
(DSGN)
Rating:Informative Buy
Date:Mar 25, 2024 - Today
Return:+55.80%
The most profitable trade made by Heather A. Berger

Heather A. Berger's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ETTX
Entasis Therapeutics Holdings
Jul 11, 2022
Uninformative Sell
48.40K
$0.00
Design Therapeutics
Mar 25, 2024
Director
Informative Buy
4.86K
$8.59K
List of latest transactions for each holding click on a transaction to see Heather A. Berger's performance on stock

Heather A. Berger insider profile FAQ

What is the percentage of profitable transactions made by Heather A. Berger?
The percentage of profitable transactions made by Heather A. Berger is ―.
    What is the average return per transaction made by Heather A. Berger?
    The average return per transaction made by Heather A. Berger is ―.
      What stocks does Heather A. Berger hold?
      Heather A. Berger holds: ETTX, DSGN stocks.
        What was Heather A. Berger’s latest transaction?
        Heather A. Berger latest transaction was an Informative Buy of $4.86K.
          What was Heather A. Berger's most profitable transaction?
          Heather A. Berger’s most profitable transaction was an Informative Buy of DSGN stock on March 25, 2024. The return on the trade was 55.80%.
            What is Heather A. Berger's role in Entasis Therapeutics Holdings?
            Heather A. Berger's role in Entasis Therapeutics Holdings is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.